MedPath

The effectiveness of a stretching intervention in lowering plantar pressures related to reduced ankle range of motion in people with diabetes.

Not Applicable
Completed
Conditions
Diabetes
Foot plantar pressure
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12616000230459
Lead Sponsor
niversity of Newcastle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
68
Inclusion Criteria

a) reduced ankle dorsiflexion range of motion (equinus) defined as ankle dorsiflexion range of motion of less than or equal to five degrees
b) males and females 18 years of age and over
c) with a diagnosis of diabetes confirmed by medical records
d) able to speak and read basic English

Exclusion Criteria

a) current foot ulcer
b) any amputation in the lower limb
c) any self-reported neurological condition (other than loss of sensation due to diabetes) that
may affect the lower limb such as multiple sclerosis, stroke or polio
d) surgery to the foot or lower limb involving fixation of a joint
e) any condition precluding the participant from taking part in the foot pressure assessment
or ankle stretching program, such as not being able to walk 8m unaided
f) pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak pressure under defined areas of the foot (e.g. forefoot, midfoot, heel) measured in-shoe using the pedar-x system with flexible insoles, and measured barefoot using the Tekscan HR mat pressure platform.[8 weeks and 16 weeks following baseline];Ankle dorsiflexion range of motion measured in: <br>- weightbearing using a weight-bearing lunge position, with knee extended and a digital inclinometer,<br>- non weightbearing using a modified Lidcombe template, with a force gauge and a digital inclinometer, which allows a standardised magnitude and direction of force to be applied to the ankle.[8 weeks and 16 weeks following baseline]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath